Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Stock
-
Total 13F shares
-
135,335,927
-
Share change
-
-2,618,260
-
Total reported value
-
$405,651,161
-
Put/Call ratio
-
48%
-
Price per share
-
$2.99
-
Number of holders
-
156
-
Value change
-
-$6,980,767
-
Number of buys
-
64
-
Number of sells
-
66
Institutional Holders of RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) as of Q1 2022
As of 31 Mar 2022,
RIGEL PHARMACEUTICALS INC COM - Stock (RIGL) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
135,335,927 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, Invesco Ltd., Rock Springs Capital Management LP, LORD, ABBETT & CO. LLC, Nuveen Asset Management, LLC, GREAT POINT PARTNERS LLC, and CITADEL ADVISORS LLC.
This page lists
156
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.